---

title: "Chronic fatigue syndrome linked to widespread energy, immune and vascular changes"
tags:
- ‚ûï 2025-12-25
- üß™ Biomarker
- ‚≠ê Landmark
created: '2024-02-21'
published: '2024-02-21'

---


<details>
<summary>Walitt et al. (2024)</summary>

- **Authors:** Brian Walitt, Julia L. Moore, Yi-Ying Chi, Jose G. Solis, Marisa P. Bartolomei, Nasir Malik, Andrew Mammen, John McCulloch, Patrick McGurrin, Joshua Milner, Ruin Moaddel, Geoffrey Mueller, Amrita Mukherjee, Sandra Mu√±oz, Gina Norato, Katherine Pak, Lago Pinal, Traian Popa, Michael N. Sack, Farinaz Safavi, Leorey Saligan, Brian Sellers, Stephen Sinclair, Bryan Smith, Joseph Snow, Stacey Solin, Barbara Stussman, Giorgio Trinchieri, Sara Turner, Stephenie Vetter, Carlotta Vizioli, Ashley Williams, Shanna Yang, and Avindra Nath.
- **Institutes:** National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD, USA; National Heart, Lung, and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases (NIAID); NIH Clinical Center.
- **Publisher:** Nature Communications
- **Link:** [DOI](https://doi.org/10.1038/s41467-024-45107-3)

</details>


## Summary

This landmark NIH study provides a unified biological explanation for the diverse symptoms of ME/CFS, showing it is a physical illness involving the brain, immune system, and heart. A key takeaway is the concept of "effort preference," where the brain appears unable to properly command the body to use energy, which may explain why patients feel exhausted even when their muscles are technically capable of moving. By identifying specific markers‚Äîsuch as brain activity changes and immune cell imbalances‚Äîthis research moves the field away from psychological theories and toward targeted, objective treatments. While the study was small and does not immediately provide a cure, it offers the most detailed "map" of the illness to date, validating the experiences of patients and providing a clear path for drug trials.

## What was researched?

This comprehensive study utilized "deep phenotyping" to investigate the biological basis of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome (PI-ME/CFS). Researchers performed an exhaustive array of clinical tests‚Äîranging from brain imaging and metabolic tracking to immune profiling and muscle biopsies‚Äîto identify objective biomarkers and underlying disease mechanisms.

## Why was it researched?

ME/CFS has long lacked clear, objective diagnostic markers, leading to historical skepticism about its biological reality. While previous studies identified isolated abnormalities in the immune system or metabolism, this research aimed to integrate these findings by examining a small, highly characterized group of patients in a controlled clinical environment to understand how these systems interact.

## How was it researched?

The study was an intensive, multi-disciplinary cross-sectional analysis involving 17 patients with PI-ME/CFS and 21 healthy controls. Participants underwent a multi-day in-patient evaluation at the NIH Clinical Center, which included functional MRI (fMRI) scans, cardiopulmonary exercise testing (CPET), skin and muscle biopsies, and analysis of cerebrospinal fluid (CSF). The researchers also tracked patients in metabolic chambers to monitor 24-hour energy expenditure and used advanced "omics" technologies to study gene expression and the gut microbiome.

## What has been found?

The researchers discovered that ME/CFS is characterized by distinct biological changes, notably a dysfunction in the right temporoparietal junction (TPJ) of the brain, which affects "effort preference" rather than physical capacity. This suggests the brain's ability to signal the body to exert effort is impaired, possibly due to low levels of catecholamines in the central nervous system. Additionally, the study found chronic immune activation (specifically altered B-cell subsets), evidence of autonomic dysfunction (low heart rate variability), and significant differences in how the disease manifests biologically between men and women.

## Discussion

The authors acknowledge that the study's primary limitation is its small sample size (17 patients), which was necessary for such an intensive depth of testing but limits the generalizability of some findings. They also noted a potential selection bias, as the participants had to be healthy enough to travel to and stay at the NIH for several weeks. However, they emphasize that the extreme consistency of findings across multiple biological systems strengthens the validity of the results.

## Conclusion & Future Work

The study concludes that PI-ME/CFS is a multi-system biological disorder rooted in immune-mediated brain dysfunction and altered energy management. The authors suggest that future research should focus on the "effort preference" pathways in the brain and investigate whether targeting chronic immune activation can restore normal signaling and alleviate fatigue.
